-
Priority purchase and use of selected products!
Time of Update: 2021-07-31
picture The third is to explore the implementation of medical insurance payment standards In terms of medical insurance payment, the "Notice" mentioned the expenses incurred by Shanghai insured persons using the selected coronary balloon dilatation catheters or coronary balloon drug-coated catheters, and canceled the original proportionate self-pay part, and fully included in the medical insurance payment scope , Pay directly according to the basic medical insurance regulations .
-
The fifth batch of national procurement started! The injection purchase cycle is extended! (With purchase catalog)
Time of Update: 2021-07-31
This centralized procurement involves 58 varieties and a total of 137 specifications, including oral regular-release dosage forms, sustained-release and controlled-release dosage forms, eye drops, injections, inhalants and other dosage forms (see attached table) .
-
Health Commission: Form 100 integrated Chinese and Western medicine diagnosis and treatment plans within five years
Time of Update: 2021-07-31
This time the three departments jointly issued the "Opinions", the main purpose is to promote the "mechanism, team, measures, and effective" integrated traditional Chinese and Western medicine medical model summarized in the prevention and control of the epidemic, so as to better meet the increasing needs of the people.
-
Zhengzhou was hit by floods, and Chinese medicinal materials have entered a seasonally sensitive period!
Time of Update: 2021-07-31
Analysis of rising varieties Table 1: Market price increase varieties TOP10 Zelan (price in kilograms, the same below), last year's new production volume was small, the market and production area inventory was weak, and there were pharmaceutical companies in the production area to buy goods, and the production area market rose.
-
Yiling Pharmaceutical Ranks Seventh in the TOP100 Ranking of Chinese Medicine Companies
Time of Update: 2021-07-31
Schematic diagram of Yiling Pharmaceutical's 2016-2020 operating income growth Under the leadership of the series of major innovations in TCM collateral disease theory, Yiling Pharmaceutical has won the National Science and Technology Award six times .
-
Pharmacopoeia Commission: 124 drugs and 49 general technical standards improvement tasks are released
Time of Update: 2021-07-31
Please send the electronic version of the contract according to the category to the corresponding office contact email address before March 15, 2021 .
-
Antidepressant "Futhioxetine" Chia Tai Tianqing receives first copy approval
Time of Update: 2021-07-31
At present, the product has been marketed in more than 70 countries and regions around the world, including the United States and the European Union, and was officially approved by the State Food and Drug Administration on November 21, 2017 .
Based on the huge patient demand, the market size of antidepressants in China has reached 6.
-
"Beidou" joins hands in medical treatment for the first time, empowering critical emergency first aid to "speed up again"
Time of Update: 2021-07-31
Shanghai Tenth Hospital Unveiled the Inauguration of the Neurological Intensive Wisdom Medical Diagnosis and Treatment Center "Beidou" joins hands in medical treatment for the first time, em
-
Baiyunshan Pharmaceutical Amlodipine Besylate Tablets have passed the quality and efficacy consistency evaluation of generic drugs
Time of Update: 2021-07-31
As of the announcement date, Baiyunshan Pharmaceutical General Factory has invested approximately RMB 4,378,800 in research and development expenses (unaudited) for the consistency evaluation of the drug .
-
The prevention and control of bivalent HPV vaccine reaches 84.5%. It is recommended to vaccinate as soon as possible
Time of Update: 2021-07-31
It is recommended to vaccinate as soon as possible Expert: The prevention and control rate of bivalent HPV vaccine reaches 84.
5% It is recommended to inoculate as soon as possible Expert: The prevention and control rate of bivalent HPV vaccine reaches 84.
-
The second in the country!
Time of Update: 2021-07-31
Hisun won the first imitation According to the official website of CDE, a total of 5 companies have submitted applications for the listing of lurasidone hydrochloride tablets for generic drugs.
-
Zhang Boli said that vaccination should be actively promoted in response to the delta strain
Time of Update: 2021-07-30
Zhang Boli said that vaccination should be actively promoted in response to the delta strain Zhang Boli said that vaccination should still be actively promoted in response to delta
-
Medical insurance e-vouchers activate more than 720 million users across all channels
Time of Update: 2021-07-30
Huang Huabo introduced that taking the improvement of the medical treatment experience as an example, the insured people do not need to carry a physical card, and can complete related medical services such as registration, medical insurance settlement, inspection and medicine collection through the medical insurance electronic vouchers, effectively improving the people’s medical treatment and drug purchase Experience .
-
Health Commission: 71 new confirmed cases on the 26th and 31 local cases
Time of Update: 2021-07-30
As of 24:00 on July 26, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 795 confirmed cases (including 20 severe cases), 87,245 cured and discharged cases, and 4,636 deaths.
-
315 coordinating regions across the country have opened direct settlement of ordinary outpatient expenses across provinces
Time of Update: 2021-07-30
" Jiang Chengjia, head of the Medical Security Management Center of the National Medical Insurance Administration, introduced that in terms of direct settlement of ordinary outpatient expenses across provinces, 18 provinces including Beijing, Tianjin and Hebei and the Xinjiang Production and Construction Corps Full coverage of all coordinated areas in the region has been achieved .
-
Sales progress of the second batch of nationally sourced varieties
Time of Update: 2021-07-30
A total of 77 pharmaceutical companies (including 3 foreign companies) with 32 generic names (including 3 original research drugs) won the bid for the second batch of volume purchases, with an average decrease of 53% .
-
Health Commission: 24 newly diagnosed local cases including 20 cases in Jiangsu
Time of Update: 2021-07-30
As of 24:00 on July 28, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 887 confirmed cases (including 23 severe cases), 87,288 cured and discharged cases, and 4,636 deaths.
-
National Medical Insurance Bureau: the cost of giving birth to three children is included in the scope of payment for maternity insurance
Time of Update: 2021-07-30
The National Medical Insurance Administration resolutely implements the decisions and deployments of the Party Central Committee and the State Council, responds to the concerns of the masses as soon as possible, and issued the "Notice on Doing a Good Job in Supporting the Three-Child Policy Maternity Insurance" (Medical Insurance Office [2021] No.
-
Hutchison Whampoa declares third-generation BTK inhibitor
Time of Update: 2021-07-30
On July 27, the CDE official website showed that Hutchison Whampoa submitted a clinical application for the BTK inhibitor HMPL-760 capsule and was accepted .
Now in China, BTK inhibitors can be called PD-1 in the field of chemical drugs, and 18 domestic projects and 8 imported drug projects have entered the clinical stage .
-
Smart healthcare is ushering in a period of development opportunity Sun Yuhang, President of Tide Pharmaceuticals: Helping more patients with digital means
Time of Update: 2021-07-30
" He Xiaohui, brand director of TusHoldings, said in an interview with a reporter from China Economic Times that the new generation of information technology is accelerating The deep integration of various economic and social fields has become a key driver for promoting the digital, networked, and intelligent transformation and upgrading of the economy and society .
